Major Korean cosmetics and household/health products maker (Whoo, Ohui, toiletries, beverages), rival to Amorepacific.
Major Korean cosmetics and household/health products maker (Whoo, Ohui, toiletries, beverages), rival to Amorepacific.
Sells cosmetics through department stores, duty-free shops and China, with the luxury Whoo line the profit anchor; household goods and a beverage business that bottles and sells Coca-Cola drinks in Korea give steadier cash. LG Corp is the controlling shareholder.
Moat: narrow (brand, distribution). Whoo is a top luxury K-beauty brand with strong China/duty-free distribution.
Headquarters: Seoul, South Korea · Founded: 1947 · Employees: 4,013
Size LG H&h (051900.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $2.81B, the 105th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩244,000 on 18 Nov 2026.
Performance Over six months the shares fell 13.8%, against +11.1% for the median peer and -37.2% for the South Korea market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue fell 3.2% over the last twelve months (peer median +3.3%); the operating margin is 3.3% (peer median 11.5%).
Valuation It trades at 23.1× forward earnings against a peer median of 21.7× (11th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -5% a year for seven years (Req g). Recent delivered growth is -4%, so the hurdle is -0 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.2 points below its cost of capital (5.5% WACC).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩6.28T | ₩6.36T | ₩6.81T | ₩6.80T | ₩7.19T |
| Revenue growth | — | -7% | 0% | -5% | — |
| Gross profit | ₩3.03T | ₩3.02T | ₩3.43T | ₩3.48T | ₩3.85T |
| EBITDA | ₩436B | ₩410B | ₩715B | ₩757B | ₩999B |
| Net income | -₩85.4B | -₩100B | ₩189B | ₩143B | ₩237B |
| Free cash flow | ₩419B | ₩368B | ₩397B | ₩507B | ₩340B |
| Capital expenditure | ₩88.6B | ₩94.6B | ₩147B | ₩164B | ₩166B |
| Total debt | ₩144B | ₩219B | ₩441B | ₩347B | ₩443B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| LG H&h 051900.KS | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% |
| Amorepacific 090430.KS | $6.01B | 0% | +10% | 9% | 24.4× | 3.6% |
| Cosmax 192820.KS | $2.51B | +53% | +25% | 8% | 18.8× | n/a |
| Estée Lauder Companies (The) EL | $37.7B | +34% | +6% | 13% | 29.4× | 16.2% |
| L'Oreal OR.PA | $259B | +20% | +3% | 21% | 32.3× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 051900.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.6% | +4.9% | 3rd lowest of 21 |
| 6-month return | -13.8% | +11.1% | 3rd lowest of 21 |
| Distance from 52-week high | -27.3% | -17.7% | 7th lowest of 21 |
| Revenue growth (TTM) | -3.2% | +3.3% | 3rd lowest of 21 |
| Operating margin | 3.3% | 11.5% | 2nd lowest of 21 |
| Forward P/E | 23.1× | 21.7× | 11th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -4.6% | -1.6% | 6th least demanding of 18 |
| Growth delivered (Del g) | -4.1% | +5.6% | lowest of 18 |
| Hurdle (Req g minus delivered) | -0.5 pp | -4.0 pp | 6th most demanding of 18 |
| ROIC minus cost of capital | -2.2 pp | +5.1 pp | 3rd lowest of 20 |
| EV / EBITDA | 6.2× | 10.4× | 2nd cheapest of 18 |
| Net debt / EBITDA | -2.7× | -0.6× | 4th least indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| LG H&h 051900.KS | South Korea | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% | -4.1% |
| Proya Cosmetics 603605.SS | China | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% | +23.1% |
| Gillette India GILLETTE.NS | India | $2.53B | -5% | +8% | 28% | 37.1× | 14.9% | +13.0% |
| Winner Medical 300888.SZ | China | $2.53B | -6% | +4% | 11% | 19.9× | -5.2% | -2.6% |
| Cosmax 192820.KS | South Korea | $2.51B | +53% | +25% | 8% | 18.8× | n/a | n/a |
| Giant Biogene 2367.HK | Hong Kong | $2.47B | -32% | -10% | 32% | 8.6× | -10.7% | +34.9% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.25B | +20% | +2% | 6% | 48.7× | 18.0% | +1.9% |
| Hengan Int'l 1044.HK | Hong Kong | $3.27B | -12% | +2% | 11% | 9.1× | -8.2% | -0.1% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.37B | -30% | -2% | 24% | 27.0× | 21.2% | +7.4% |
| Interparfums ITP.PA | France | $3.49B | +66% | -4% | 18% | 26.9× | 15.6% | +19.6% |
| Softcare 2698.HK | Hong Kong | $2.20B | +5% | +25% | 25% | 14.4× | 9.1% | +20.9% |
| KOSE 4922.T | Japan | $2.16B | +16% | +4% | 5% | 29.9× | n/a | n/a |
| Coty COTY | United States | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% | +4.6% |
| Blue Moon 6993.HK | Hong Kong | $2.07B | -4% | -2% | -2% | 103.3× | n/a | n/a |
| Lion 4912.T | Japan | $3.85B | +44% | +6% | 8% | 24.3× | 0.9% | +3.5% |
| Kolmar Korea 161890.KS | South Korea | $2.05B | +14% | +16% | 10% | 14.3× | -1.6% | +15.5% |
| Pola Orbis 4927.T | Japan | $2.04B | +15% | +1% | 11% | 30.6× | -2.0% | -0.7% |
| Rohto Pharmaceutical 4527.T | Japan | $3.87B | +8% | +7% | 12% | 16.5× | -2.8% | +13.7% |
| Emami EMAMILTD.NS | India | $1.94B | -5% | +13% | 20% | 23.4× | 21.5% | +5.6% |
| Energizer ENR | United States | $1.94B | +71% | 0% | 17% | 9.1× | -5.1% | -0.5% |
| Pigeon 7956.T | Japan | $1.76B | +26% | +8% | 13% | 27.9× | -2.4% | +1.9% |